Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;33(5):611-620.
doi: 10.1097/WCO.0000000000000851.

The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases

Claudia Nuñez-Peralta  1   2 , Jorge Alonso-Pérez  3 , Jordi Díaz-Manera  3   4   5
Affiliations
Review

The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases

Claudia Nuñez-Peralta et al. Curr Opin Neurol. 2020 Oct.

Abstract

Purpose of review: This review aims to discuss the recent results of studies published applying quantitative MRI sequences to large cohorts of patients with neuromuscular diseases.

Recent findings: Quantitative MRI sequences are now available to identify and quantify changes in muscle water and fat content. These two components have been associated with acute and chronic injuries, respectively. Studies show that the increase in muscle water is not only reversible if therapies are applied successfully but can also predict fat replacement in neurodegenerative diseases. Muscle fat fraction correlates with muscle function tests and increases gradually over time in parallel with the functional decline of patients with neuromuscular diseases. There are new spectrometry-based sequences to quantify other components, such as glycogen, electrolytes or the pH of the muscle fibre, extending the applicability of MRI to the study of several processes in neuromuscular diseases.

Summary: The latest results obtained from the study of long cohorts of patients with various neuromuscular diseases open the door to the use of this technology in clinical trials, which would make it possible to obtain a new measure for assessing the effectiveness of new treatments. The challenge is currently the popularization of these studies and their application to the monitoring of patients in the daily clinic.

PubMed Disclaimer

References

    1. Wicklund MP, Kissel JT. The limb-girdle muscular dystrophies. Neurol Clin 2019; 32:729749,ix.
    1. Angelini C, Marozzo R, Pegoraro V. Current and emerging therapies in Becker muscular dystrophy (BMD). Acta Myol 2019; 38:172179.
    1. Mercuri E, Bönnemann CG, Muntoni F. Muscular dystrophies. Lancet 2019; 394:20252038.
    1. Ravi B, Antonellis A, Sumner CJ, Lieberman AP. Genetic approaches to the treatment of inherited neuromuscular diseases. Hum Mol Genet 2019; 28:R55R64.
    1. Doudna JA. The promise and challenge of therapeutic genome editing. Nature 2020; 578:229236.

Publication types

MeSH terms